MCID: URC003
MIFTS: 19

Urachal Adenocarcinoma malady

Categories: Rare diseases, Cancer diseases

Aliases & Classifications for Urachal Adenocarcinoma

About this section

Aliases & Descriptions for Urachal Adenocarcinoma:

Name: Urachal Adenocarcinoma 45 65
 
Adenocarcinoma of the Urachus 45

Classifications:



External Ids:

UMLS65 C2931201

Summaries for Urachal Adenocarcinoma

About this section
MalaCards based summary: Urachal Adenocarcinoma, also known as adenocarcinoma of the urachus, is related to bladder urachal adenocarcinoma and leukemia. An important gene associated with Urachal Adenocarcinoma is AFP (Alpha Fetoprotein). Affiliated tissues include brain, breast and lung.

Related Diseases for Urachal Adenocarcinoma

About this section

Graphical network of the top 20 diseases related to Urachal Adenocarcinoma:



Diseases related to urachal adenocarcinoma

Symptoms for Urachal Adenocarcinoma

About this section

Drugs & Therapeutics for Urachal Adenocarcinoma

About this section

Drugs for Urachal Adenocarcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 13)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
GemcitabineapprovedPhase 2188195058-81-460750
Synonyms:
103882-84-4
122111-03-9
2',2'-DiF-dC
2',2'-Difluoro-2'-deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-.beta.-D-2',2'-difluorocytidine
2'-Deoxy-2',2'-difluorocytidine
4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one
4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
95058-81-4
AB1004842
AC1L1TUQ
C07650
CCRIS 8984
CHEBI:175901
CHEMBL888
CID60750
Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine
D02368
DB00441
DDFC
DFDC
DFdC
DFdCyd
Folfugem
GEO
Gamcitabine
GemLip
Gemcel
 
Gemcin
Gemcitabin
Gemcitabina
Gemcitabina [INN-Spanish]
Gemcitabine
Gemcitabine (USAN/INN)
Gemcitabine HCl
Gemcitabine Hydrochloride
Gemcitabine hydrochloride
Gemcitabine stereoisomer
Gemcitabinum
Gemcitabinum [INN-Latin]
Gemtro
Gemzar
Gemzar (hydrochloride)
HMS2089P10
HSDB 7567
Inno-D07001
LS-59139
LY 188011
LY-188011
LY188011
NCGC00168784-01
NChemBio.2007.10-comp25
NSC 613327
NSC613327
TL8005979
UNII-B76N6SBZ8R
ZINC18279854
Zefei
gemcitabine
nchembio.573-comp7
nchembio.90-comp2
2
leucovorinapprovedPhase 29521492-18-854575
Synonyms:
(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid
(6S)-Folinic acid
(6S)-Leucovorin
(S)-Leucovorin
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid-SF
Fusilev
 
L-Folinic acid
L-leucovorin
Leucal
Leucovorin
Leucovorin Calcium
Leucovorin calcium
Leucovorin folinic acid
Leucovorin sodium
Leukovorin
Levofolene
Levofolinic acid
Levoleucovorin
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid
Wellcovorin
3
CisplatinapprovedPhase 2254015663-27-184093, 441203, 2767
Synonyms:
(SP-4-1)-diamminedichloridoplatinum
(SP-4-1)-diamminedichloroplatinum
(SP-4-2)-diamminedichloridoplatinum
(SP-4-2)-diamminedichloroplatinum
Abiplatin
Biocisplatinum
Briplatin
CACP
CDDP
CHEBI:35852
CID441203
CPD0-1392
CPDC
CPDD
Carboquone
Cis Pt II
Cis-DDP
Cis-Diaminedichloroplatinum
Cis-Diamminedichloroplatinum
Cismaplat
Cisplatin
Cisplatine
Cisplatino
Cisplatinum
Cisplatyl
Citoplationo
DB00515
DDP
DDPT
Diamminedichloroplatinum
 
EU-0100918
Lederplatin
Neoplatin
Peyrone's chloride
Peyrone's salt
Plastin
Platamine
Platiblastin
Platidiam
Platinex
Platinol
Platinol-AQ
Platinol-aq
Platinoxan
Platinum Ammine Chloride
Platinum Ammonium Chloride
Platinum Diamine Dichloride
Randa
Trans-DDP
Trans-Diaminedichloroplatinum
Trans-Diamminedichloroplatinum
Trans-Dichlorodiammine Platinum
Trans-Platinumdiammine Dichloride
cis-DDP
cis-Diamminedichloroplatinum
cis-Dichlorodiammineplatinum(II)
cis-[PtCl2(NH3)2]
cis-diamminedichloridoplatinum(II)
cis-diamminedichloroplatinum(II)
nchembio773-comp1
trans-diamminedichloridoplatinum(II)
4
FluorouracilapprovedPhase 2168451-21-83385
Synonyms:
1-fluoro-1h-pyrimidine-2,4-dione
1004-03-1
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 FU Lederle
5 FU medac
5 Fluorouracil
5 Fluorouracil biosyn
5 HU Hexal
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5-HU Hexal
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-fluoropyrimidine-2,4(1H,3H)-dione
5-fluorouracil
51-21-8
5FU
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AI3-25297
AKOS000119162
AKOS003237897
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
BSPBio_002048
C07649
C4H3FN2O2
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
CPD0-1327
CPD000038082
CSP Brand of Fluorouracil
Carac
Carac (TN)
Carzonal
Cinco FU
Cytosafe
D005472
D00584
DB00544
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
EINECS 200-085-6
EU-0100536
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
FT-0082524
FU
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoro-Uracile ICN
Fluoro-uracile
Fluoro-uracilo
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracil [USAN:INN:BAN:JAN]
 
Fluorouracil-GRY
Fluorouracile
Fluorouracile Dakota
Fluorouracile [DCIT]
Fluorouracilo
Fluorouracilo Ferrer Far
Fluorouracilo [INN-Spanish]
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
Ftoruracil
Gry Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
LS-153
Lopac-F-6627
Lopac0_000536
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
NCI60_001652
NINDS_000054
NSC 19893
NSC-19893
NSC19893
Neocorp Brand of Fluorouracil
Neofluor
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
SPECTRUM1500305
STK297802
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
Spectrum_000841
T5233394
TL8006093
Teva Brand of Fluorouracil
Timazin
U 8953
U-8953
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
Ulup
WLN: T6MVMVJ EF
ZINC00897110
biosyn Brand of Fluorouracil
fluorouracil
inhibits thymilidate synthetase
medac Brand of Fluorouracil
nchembio.90-comp3
nchembio809-comp6
ribosepharm Brand of Fluorouracil
tetratogen
5Immunosuppressive AgentsPhase 210422
6AntimetabolitesPhase 29454
7LevoleucovorinPhase 2676
8Immunologic FactorsPhase 218483
9Antimetabolites, AntineoplasticPhase 25770
10Antiviral AgentsPhase 28071
11Anti-Infective AgentsPhase 217220
12tyrosineNutraceuticalPhase 2596
13Folinic AcidNutraceuticalPhase 22604

Interventional clinical trials:

idNameStatusNCT IDPhase
1Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal RemnantActive, not recruitingNCT00082706Phase 2
2Cabozantinib for Advanced Urothelial CancerActive, not recruitingNCT01688999Phase 2

Search NIH Clinical Center for Urachal Adenocarcinoma

Genetic Tests for Urachal Adenocarcinoma

About this section

Anatomical Context for Urachal Adenocarcinoma

About this section

MalaCards organs/tissues related to Urachal Adenocarcinoma:

33
Brain, Breast, Lung, B cells, Testes, Pituitary, T cells

Animal Models for Urachal Adenocarcinoma or affiliated genes

About this section

Publications for Urachal Adenocarcinoma

About this section

Articles related to Urachal Adenocarcinoma:

(show top 50)    (show all 55)
idTitleAuthorsYear
1
Natural history of brain capillary vascular malformations in hereditary hemorrhagic telangiectasia patients. (26919971)
2016
2
Primary Mediastinal large B-Cell Lymphoma as an incidental finding: report of a case. (27094863)
2016
3
Fibulin-5 inhibits Wnt/I^-catenin signaling in lung cancer. (25909283)
2015
4
Insecticide resistance alleles in wetland and residential populations of the West Nile virus vector Culex pipiens in New Jersey, USA. (25809655)
2015
5
New Biomolecular Approaches to the Treatment of Glioblastoma Multiforme. (25894780)
2015
6
Heerlen polymorphism associated with type III protein S deficiency and factor V Leiden mutation in a Polish patient with deep vein thrombosis. (24365770)
2014
7
MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating Ga88/S transition and apoptosis by targeting p21(WAF1/CIP1). (24921914)
2014
8
Utility of diffusion-weighted MRI in the diagnosis of bladder carcinoma. (23911157)
2013
9
Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor. (23382471)
2013
10
Solitary plasmacytoma of skull: a rare cytological diagnosis. (24086882)
2013
11
Schizophrenia-related RGS4 gene variations specifically disrupt prefrontal control of saccadic eye movements. (21910931)
2012
12
DC-SCRIPT: AR and VDR regulator lost upon transformation of prostate epithelial cells. (22473304)
2012
13
Angiosarcoma involving solid organs and the gastrointestinal tract with life-threatening bleeding. (23341800)
2012
14
Rapidly progressing giant invasive prolactinoma. (22804858)
2012
15
Expression and prognostic assessment of dipeptidyl peptidase IV and related enzymes in B-cell chronic lymphocytic leukemia. (20534982)
2010
16
Primary ALK-1-negative anaplastic large cell lymphoma of the brain: case report and review of the literature. (18564100)
2009
17
Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells. (19489688)
2009
18
Pro-angiogenic cytokines as cardiovascular therapeutics: assessing the potential. (18611064)
2008
19
Bilateral cavernous internal carotid aneurysms in a child with juvenile paget disease and osteoprotegerin deficiency. (17947367)
2008
20
Case 32-2007: bilateral breast cancer. (18305276)
2008
21
Long-term sustained benefits of clozapine treatment in refractory early onset schizophrenia: a retrospective study in Korean children and adolescents. (18814190)
2008
22
Fenofibrate inhibits intestinal Cl- secretion by blocking basolateral KCNQ1 K+ channels. (17916649)
2007
23
Impact of air pollution and genotype variability on DNA damage in Prague policemen. (17590289)
2007
24
The environmental pollutant and carcinogen 3-nitrobenzanthrone and its human metabolite 3-aminobenzanthrone are potent inducers of rat hepatic cytochromes P450 1A1 and -1A2 and NAD(P)H:quinone oxidoreductase. (16714372)
2006
25
Conjunctival mucoepidermoid carcinoma in a patient with ocular cicatricial pemphigoid and a review of the literature. (16950250)
2006
26
Mechanism of insulin gene regulation by the pancreatic transcription factor Pdx-1: application of pre-mRNA analysis and chromatin immunoprecipitation to assess formation of functional transcriptional complexes. (15743769)
2005
27
Differential expression patterns of gangliosides in the ischemic cerebral cortex produced by middle cerebral artery occlusion. (16404149)
2005
28
Lead reduces messenger RNA and protein levels of cytochrome p450 aromatase and estrogen receptor beta in human ovarian granulosa cells. (12606482)
2003
29
The 17q23 amplicon and breast cancer. (12755490)
2003
30
Treatment of mediastinitis using an open irrigation and delayed sternal reconstruction with a pectoralis major muscle flap. (14558298)
2003
31
Amelioration of tacrolimus-induced nephrotoxicity in rats using juniper oil. (12883183)
2003
32
BRCA1 regulates the interferon gamma-mediated apoptotic response. (12011077)
2002
33
HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. (11479183)
2001
34
Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. (10615119)
2000
35
Effects of cholinergic muscarinic blockade on growth hormone responses to growth hormone-releasing hormone in uraemic patients. (10435880)
1999
36
An N-terminal fragment of titin coupled to green fluorescent protein localizes to the Z-bands in living muscle cells: overexpression leads to myofibril disassembly. (9247649)
1997
37
Assessment of French patients with LPL deficiency for French Canadian mutations. (9279761)
1997
38
Cloning of guinea pig cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase complementary deoxyribonucleic acids: steroid-modulated gene expression correlates to prostaglandin F2 alpha secretion in cultured endometrial cells. (8977409)
1997
39
A comparison between short ACTH and insulin stress tests for assessing hypothalamo-pituitary-adrenal function. (8706316)
1996
40
A phase II trial of weekly infusional 5-fluorouracil in combination with low-dose leucovorin in patients with advanced colorectal cancer. (8729951)
1995
41
Isolated growth hormone deficiency: testing the little mouse hypothesis in man and exclusion of mutations within the extracellular domain of the growth hormone-releasing hormone receptor. (8618801)
1995
42
Pulmonary blastomycosis in children: findings on chest radiographs. (7645488)
1995
43
A cost comparison of laboratory charges in treating childhood leukemia. A children's cancer group analysis. (8166361)
1994
44
Management of chronic suppurative otitis media: superiority of therapy effective against anaerobic bacteria. (8177625)
1994
45
Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. (1355373)
1992
46
Confirmation of the assignment of the vitronectin (VNRA) and fibronectin (FNRA) receptor alpha-subunits. (1722386)
1991
47
Separation of cell mixtures by immunoaffinity cell partitioning: strategies for low abundance cells. (2035832)
1991
48
5p;12q translocation with manifestations of cri du chat syndrome and Marfanoid arachnodactyly. (2311266)
1990
49
Cutaneous larva migrans in American tourists--Martinique and Mexico. (6789109)
1981
50
Xanthogranulomatous pyelonephritis. Unusual clinical presentations. (4768745)
1973

Variations for Urachal Adenocarcinoma

About this section

Expression for genes affiliated with Urachal Adenocarcinoma

About this section
Search GEO for disease gene expression data for Urachal Adenocarcinoma.

Pathways for genes affiliated with Urachal Adenocarcinoma

About this section

GO Terms for genes affiliated with Urachal Adenocarcinoma

About this section

Sources for Urachal Adenocarcinoma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet